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OBJECTIVES We sought to investigate the safety and efficacy of a protocol for acute pericarditis triage and
outpatient management of low-risk cases.
BACKGROUND Acute pericarditis has generally a brief and benign course after empiric treatment by
non-steroidal anti-inflammatory drugs, and routine hospitalization of most patients may be
unnecessary.
METHODS From January 1996 to December 2001, all consecutive cases of acute pericarditis were
evaluated on a day-hospital basis. Patients without clinical poor prognostic predictors (fever
38°C, subacute onset, immunodepression, trauma, oral anticoagulant therapy, myopericar-
ditis, severe pericardial effusion, cardiac tamponade) were considered low-risk cases and
assigned to outpatient treatment with high-dose oral aspirin. Patients with poor prognostic
predictors or aspirin failure were hospitalized for etiology search and treatment. A clinical and
echocardiographic follow-up was performed at 48 to 72 h, 7 to 10 days, 1 month, 6 months,
and 1 year.
RESULTS Two hundred fifty-four out of 300 (84.7%) patients were selected as low-risk cases.
Outpatient treatment was efficacious in 221 out of 254 (87%) cases. Thirty-three out of 254
patients were hospitalized because of aspirin failure. Patients treated on an out-of-hospital
basis had no serious complications after a mean follow-up of 38 months (no cases of cardiac
tamponade). A higher frequency of recurrences and constriction was recorded in aspirin-
resistant cases than in aspirin responders (60.6% vs. 10.4% for recurrences and 9.1% vs. 0.5%
for constriction, respectively; all p  0.01).
CONCLUSIONS A protocol for acute pericarditis triage and outpatient therapy of low-risk cases is safe and
efficacious and may reduce management costs. (J Am Coll Cardiol 2004;43:1042–6)
© 2004 by the American College of Cardiology Foundation(
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rcute pericarditis is a common and frequent disease to be
onsidered in the differential diagnosis of chest pain. Most
atients with acute pericarditis have either viral or idio-
athic pericarditis. In many cases, acute pericarditis has a
rief and benign course after empiric treatment by non-
teroidal anti-inflammatory drugs (NSAIDs). A viral etiol-
gy is often presumed, but evidence for this is often not
ought, because of the expense involved and the time
equired before the results of laboratory tests are available.
reatment aims to relieve symptoms, and most patients are
ospitalized for complete diagnosis and observation of
omplications, particularly pericardial effusion and cardiac
amponade (1,2).
In many cases, neither the performance of tests to
stablish a specific etiologic diagnosis nor hospitalization of
he patient may be necessary. However, it is important to
etermine in every patient whether significant effusion or
amponade is present and to be able to select patients at
igh risk of complications who really need hospitalization.
After a review of the literature reporting previous series
From the Cardiology Department, Maria Vittoria Hospital, Turin, Italy.
Manuscript received April 16, 2003; revised manuscript received August 21, 2003,rccepted September 9, 2003.3,4), we developed a protocol for acute pericarditis triage
n a day-hospital basis and for outpatient management of
ow-risk cases. The aim of this work is to investigate the
afety and efficacy of this protocol.
ETHODS
tudy protocol. From January 1996 to December 2001, we
rospectively studied all consecutive cases of acute pericar-
itis on a day-hospital basis. Acute pericarditis was diag-
osed when at least two of the following criteria were
resent: pericarditic chest pain, pericardial friction rub, and
idespread ST-segment elevation on the electrocardiogram
ECG) (1–3). All patients had M-mode, two-dimensional,
nd Doppler echocardiographic studies performed using a
ewlett-Packard Sonos 2500 or 5500 machine (Palo Alto,
alifornia).
Considering that most cases probably had a viral or
diopathic etiology, with a possible brief and benign course
fter NSAIDs, we intentionally avoided performing an
nitial full diagnostic evaluation in all cases. We selected
atients on the basis of a clinical examination, results of
outine laboratory tests (blood cell count, sedimentation
ate, acute-phase reactants, creatine kinase [CK], CK-MB,
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acic echocardiography to determine the amount of pericar-
ial effusion. Following the criteria of Weitzman et al. (6),
e considered a small effusion as an echo-free space (ante-
ior plus posterior) of 10 mm during diastole, a moderate
ffusion as an echo-free pericardial space of 10 to 20 mm,
nd a severe effusion as an echo-free space of 20 mm.
Patients without clinical or echocardiographic poor prog-
ostic predictors were considered at low risk (Fig. 1) and
ssigned to outpatient treatment with high-dose oral aspi-
in. A clinical and echocardiographic follow-up was per-
ormed at 48 to 72 h, 7 to 10 days, 1 month, 6 months, and
year in non-complicated cases. Patients with clinical and
chocardiographic poor prognostic predictors or patients
ithout a response to aspirin were considered high-risk
atients to be studied and treated after hospitalization. In
hese cases, a complete search for specific causes was
erformed. We considered aspirin failure in case of an
nfavorable clinical reaction with persistence of fever, peri-
ardial effusion appearance, or worsening and general illness
asting more than seven days despite treatment with a full
ose of aspirin.
ay-hospital care. Day-hospital care consists of a pro-
rammed patient admission during the daytime, without
raditional hospitalization with a night stay. Patients can
ave laboratory tests, diagnostic examinations, and therapies
n the daytime and are discharged on the same day.
ay-hospital care commonly reduces the need for a full
ospitalization and management charges.
For acute pericarditis, day-hospital care included a tradi-
Abbreviations and Acronyms
CK  creatine kinase
ECG  electrocardiogram/electrocardiograph/
electrocardiographic
NSAIDs  non-steroidal anti-inflammatory drugs
RR  relative risk
igure 1. Initial clinical and echocardiographic evaluation of patients with
puspected acute pericarditis, according to the study protocol.ional patient evaluation with physical examination, ECG,
aboratory tests (if necessary), and echocardiography, offer-
ng a more complete approach to the patient with acute
ericarditis than a simple outpatient visit. Low-risk cases
ere observed for a period of several hours, generally the
ime required to perform protocol examinations; then,
atients were discharged on the same day without a night
tay and returned for scheduled follow-up visits. Follow-up
isits were performed on a day-hospital basis and included
t least a focused history, physical examination, and echo-
ardiogram; ECG and laboratory tests were included if
ecessary, according to clinical judgment.
oor prognostic predictors. After a literature review, we
dentified as “poor prognostic predictors” those clinical
eatures that were more frequently associated with an
ncreased risk of short-term complications or a high likeli-
ood of a specific disease. These clinical features included
ever 38°C (7–9), subacute onset (3,10,11), immunode-
ression (11,12), trauma (1,11), oral anticoagulant therapy
1,13), myopericarditis (1,14), severe pericardial effusion,
nd cardiac tamponade (3,4,10).
rug treatment. Aspirin was given at the dose of 800 mg
rally every 6 or 8 h for 7 to 10 days, with gradual tapering
ver two to three weeks; commonly, the aspirin dose was
educed by 800 mg/day every week. Aspirin dose-tapering
as prescribed in an attempt to reduce the recurrence rate,
s suggested by our previously unpublished experience and
ecommended by Spanish guidelines on the management of
cute pericarditis (15). Aspirin side effects were recorded.
e considered serious or major adverse effects, events such
s allergic reactions, peptic ulcer, and gastrointestinal bleed-
ng which resulted in drug withdrawal.
We recommended a gastroprotection with misoprostol
600 to 800 g/day) or omeprazole (20 mg/day). The
ationale for this recommendation is based on published
ata (1,16,17). Several studies have evaluated factors that
lace patients at increased risk of gastroduodenal toxicity
rom NSAIDs. A committee appointed by the American
ollege of Gastroenterology (16) identified the five most
mportant risk factors: age 60 years (relative risk [RR]
.52), a history of an adverse gastroduodenal event (RR
.76), high-dosage NSAIDs (more than twice normal; RR
0.1), concurrent use of glucocorticoids (RR 4.4), and
oncurrent use of anticoagulants (RR 12.7). Patients with
everal risk factors are at highest risk of NSAID-induced
astroduodenal toxicity. Our protocol includes a high dos-
ge of aspirin for more than one week, on an outpatient
asis. Thus, our patients have at least one major risk factor
or gastroduodenal toxicity. Moreover, another possible risk
actor (17) is also the duration of NSAID therapy (more
han 1 week but less than 3 months).
tatistical analysis. Continuous data are reported as the
ean value  SD and compared using the unpaired t test.
ategorical variables are expressed as proportions or per-
entages and compared using chi-square analysis. A value of
 0.05 was considered to show statistical significance.
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uring the study period, we observed 300 new cases of
cute pericarditis (mean age 51.3  17.1 years [range 16 to
0 years]; 194 men and 106 women [male/female ratio of
.83]).
At presentation, pericardial chest pain was present in 295
98.3%) patients, pericardial friction rub in 105 (35.0%)
ases, and ECG ST-segment elevation in 268 (89.3%) cases
ith a typical ECG evolution in 161 (60.1%) of 268 cases.
Pericardial effusion was present in 180 patients (60.0%):
ild effusion in 143 (79.4%), moderate in 18 (10.0%), and
evere in 19 (10.6%). Cardiac tamponade was present in 15
5.0%) of 300 cases. An acute onset was present in 267
89.0%) of 300 cases.
After a clinical and echocardiographic evaluation, 254
84.7%) of 300 patients were selected as low-risk cases and
reated on an outpatient basis, as stated in the protocol.
mong low-risk cases, outpatient treatment was effective in
21 (87.0%) of 254 cases (group I). In 33 (13.0%) of 254
ases (group II), initial treatment with aspirin was ineffec-
ive, and the patients were hospitalized. A clinical response
as observed after administration of corticosteroids in 27
ases and after antituberculosis therapy in six cases.
In group I, we did not routinely obtain viral studies, as the
ield is low and management is not altered by laboratory
Table 1. Clinical Features and Follow-Up Res
Response to Aspirin
Response to
Yes
(n  221/254 [
Age (yrs) 50.6  17
Male gender 131 (59.3
Acute onset 210 (95.0
ST-segment elevation 201 (91.0
Pericardial effusion 130 (58.8
Etiology*
Presumed idiopathic/viral 217 (98.2
Autoimmune disorders† 4 (1.8%
Tuberculosis 0
Follow-up (months) 37.5  28
Cardiac tamponade 0
Recurrent pericarditis 23 (10.4
Constrictive pericarditis 1 (0.5%
*A full diagnostic evaluation was performed only in aspirin
according to the study protocol. †Including connective tissue
the mean value  SD or number (%) of cases.
NS  not significant.
able 2. Etiology of Acute Pericarditis According to Clinical
isk Groups
Etiology*
Low Risk
(n  254)
Moderate to
High Risk
(n  46)
p
Value
resumed idiopathic/viral 230 (90.6%) 10 (21.7%) 0.001
pecific etiology 24 (9.4%) 36 (78.3%) 0.001
A full diagnostic evaluation was performed in aspirin-resistant cases (n  33) for
aow-risk patients and in all moderate to high-risk patients.ests results. In these cases with a response to aspirin
reatment, our final diagnosis was idiopathic pericarditis. In
roup II, after a complete search for specific causes, we
bserved 13 cases of idiopathic pericarditis, 10 cases of
ericarditis secondary to connective tissue diseases, 6 cases
f tuberculous pericarditis, and 4 post-pericardiotomy syn-
romes. A comparison of clinical and echocardiographic
eatures between group I and group II is reported in Table
. Idiopathic and specific etiology frequencies in low-risk
ersus moderate- to high-risk cases are reported in Table 2.
The gastroprotection protocol with misoprostol or ome-
razole was efficacious. Aspirin treatment was well tolerated
ithout serious drug side effects. We recorded only minor
ide effects, including dyspepsia, abdominal pain, and gas-
ritis, in 8 (3.2%) of 254 cases.
After a mean follow-up of 38 months in the overall group
ith low-risk acute pericarditis (n  254), we observed 43
ases of relapses (16.9%), four cases of constrictive pericar-
itis (1.6%), and no cases of cardiac tamponade. After
ubgroup analysis, we observed a greater number of com-
lications in patients who did not respond to the initial
herapy with aspirin (Table 1; all p  0.01).
ISCUSSION
ajor findings. Acute pericarditis diagnosis was per-
ormed according to commonly accepted diagnostic criteria
1–3). As an incidental finding of repeated examinations, we
onfirmed the poor sensitivity of pericardial friction rub
hich is one of the diagnostic criteria and is considered the
athognomonic specific physical finding of acute pericardi-
is (18). Pericardial friction rub is frequently evanescent and
ay vary in intensity and characteristics, even during a
ingle day. Furthermore, it may disappear at times; thus,
f Patients With or Without an Initial
irin Treatment for 7–10 Days
p Value])
No
(n  33/254 [13.0%])
55.6  13.6 NS
11 (33.3%) 0.009
30 (90.9%) NS
30 (90.9%) NS
19 (57.6%) NS
13 (39.4%) 0.001
14 (42.4%) 0.001
6 (18.2%) 0.001
39.5  27.5 NS
0 NS
20 (60.6%) 0.001
3 (9.1%) 0.004
tant cases and in patients with poor prognostic predictors
e and post-pericardiotomy syndromes. Data are presented asults o
Asp
87.0%
.4
%)
%)
%)
%)
%)
)
.9
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)
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diseasdequate evaluation sometimes may require careful and
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March 17, 2004:1042–6 Management Program for Outpatient Therapyepeated examination. The presence of pericardial rub guar-
ntees the diagnosis, but its absence does not exclude it.
To the present, this is the largest reported group of
nselected patients with acute pericarditis and the first study
o test formally the safety and efficacy of a diagnostic and
herapeutic approach for acute pericarditis triage and out-
atient treatment of low-risk cases.
Our diagnostic and therapeutic protocol is based on
atient triage by clinical and echocardiographic evaluation.
chocardiography can be very helpful in confirming the
iagnosis of pericarditis, disclosing even a small effusion,
nd it is very useful to rule out important complications such
s cardiac tamponade and myopericarditis. Patients without
linical or echocardiographic poor prognostic predictors
fever 38°C, subacute onset, immunodepression, trauma,
ral anticoagulant therapy, myopericarditis, severe pericar-
ial effusion, cardiac tamponade) were considered at low
isk. In many of such patients, even an extensive diagnostic
valuation is likely to result in negative etiologic conclusions
2–4). Therefore, we did not routinely obtain viral studies,
s the yield is low and management is not altered. This
pproach may change with the introduction of new treat-
ents for specific viral infections into clinical practice.
ow-risk cases of acute pericarditis were assigned to day-
ospital treatment with high-dose oral aspirin (800 mg
rally every 6 or 8 h for 7 to 10 days, with gradual tapering
ver 2 to 3 weeks) and gastroprotection with misoprostol or
meprazole.
Overinvestigation leading to inappropriate intervention is
common problem in managing acute pericarditis. Appli-
ation of a conservative management protocol and gradual
apering of aspirin might be particularly important to reduce
he risk of recurrences that were present in 43 (16.9%) of
54 patients of low-risk cases in our group, whereas the
eported recurrence rate after an initial attack of idiopathic
ericarditis may be as high as 32% (19,20). As previously
eported (3,4), the initial response to aspirin identified a
roup of patients with a good outcome and a low risk of
omplications. Application of this protocol led to a specific
iagnosis in 60 (20.0%) of 300 cases in the unselected group
14% to 22% of cases in previously published data) (3,4) but
p to 36 (78.3%) of 46 moderate- to high-risk patients who
ere hospitalized (Table 2), showing the possible impor-
ance and utility of patient selection to initiate a search for
specific etiologic diagnosis.
Outpatient treatment was efficacious in 221 (87%) of 254
ases. Patients treated on a day-hospital basis had no serious
omplications during follow-up (no cases of cardiac tam-
onade). Aspirin was at least as safe and efficacious as more
ecent and expensive NSAIDs commonly recommended in
ecent reports.
A program for outpatient treatment of acute pericarditis
n low-risk cases is probably not only safe and efficacious but
lso cost-effective in reducing hospitalization rates and
anagement costs.tudy limitations. No studies have formally tested the
afety and efficacy of out-of-hospital treatment of acute
ericarditis. Some limitations of our study must be acknowl-
dged. To study the validity of a protocol for day-hospital
reatment of low-risk cases, we performed a prospective
ohort study. A possible study limitation is the lack of a
ontrol group; all patients were stratified by clinical risk, and
ll low-risk cases were treated on an outpatient basis.
owever, the comparison with published data shows that
his protocol is at least as safe and efficacious as previous
eries of hospitalized patients (3,4). Moreover, out-of-
ospital treatment with aspirin was efficacious in the ma-
ority of low-risk cases (87%), and no serious complications
ere detected during a mean follow-up of 38 months. Even
ithout a control group, this prospective cohort study
rovides evidence that a management program delivered by
ay-hospital care could be safe and efficacious in the
reatment of acute pericarditis in low-risk cases and may
educe management costs. The main novelty of the present
tudy is to propose acute pericarditis risk stratification in
rder to select low-risk cases to be treated on an out-of-
ospital basis.
To date, even though this was a single-center, observa-
ional study, this report represents the largest survey of
atients with acute pericarditis who were stratified by
linical risk and evaluated for out-of-hospital treatment of
ow-risk cases.
onclusions. Day-hospital care of low-risk cases of acute
ericarditis is safe and efficacious and may reduce manage-
ent costs. A lack of an initial response to aspirin can
dentify a group of patients at greater risk of relapses and
omplications. Acute pericarditis risk stratification based on
linical and echocardiographic evaluation could be useful to
elect the appropriate care setting (day-hospital vs. hospi-
alization) as well as high-risk cases (Fig. 1). High-risk
atients need to be hospitalized for a specific etiology search
nd more intensive follow-up.
cknowledgment
he authors gratefully acknowledge Marco Bobbio, MD,
or his help in the critical review of the manuscript.
eprint requests and correspondence: Dr. Massimo Imazio,
.so Trapani 195/A 10141 Torino, Italy. E-mail: imazio@tin.it.
EFERENCES
1. Spodick DH. Pericardial disease. Braunwald E, Zipes D, Libby P,
editors. Heart Disease: A Textbook of Cardiovascular Medicine.
Philadelphia, PA: W.B. Saunders, 2001.
2. Spodick DH. Acute pericarditis: current concepts and practice. JAMA
2003;289:1150–3.
3. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary
acute pericardial disease: a prospective series of 231 consecutive
patients. Am J Cardiol 1985;56:623–30.
4. Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and
role of methods for specific etiologic diagnosis of primary acute
pericarditis. Am J Cardiol 1995;75:378–82.
11
1
1
1
1
1
1
1
1
2
1046 Imazio et al. JACC Vol. 43, No. 6, 2004
Management Program for Outpatient Therapy March 17, 2004:1042–65. Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute
pericarditis. J Am Coll Cardiol 2003;42:2144–8.
6. Weitzman LB, Tinker WP, Kronzon I, et al. The incidence and
natural history of pericardial effusion after cardiac surgery: an echo-
cardiographic study. Circulation 1984;69:506–11.
7. Rubin RH, Moellering RC Jr. Clinical, microbiologic and therapeutic
aspects of purulent pericarditis. Am J Med 1975;59:68–78.
8. Sagrista`-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J.
Purulent pericarditis: review of a 20-year experience in a general
hospital. J Am Coll Cardiol 1993;22:1661–5.
9. Khan AH. The postcardiac injury syndromes. Clin Cardiol 1992;15:
67–72.
0. Soler-Soler J, Permanyer-Miralda G, Sagrista`-Sauleda J. A systematic
diagnostic approach to primary acute pericardial disease: the Barcelona
experience. Cardiol Clin 1990;8:609–20.
1. Geslin P. Acute pericarditis: etiology, diagnosis, course, complications,
treatment. Rev Prat 1993;43:2563–7.
2. DeCastro S, Migliau G, Silvestri A, et al. Heart involvement in AIDS:
a prospective study during various stages of the disease. Eur Heart J
1992;13:1452–9.3. Malouf JF, Alam S, Gharzeddine W, Stefadouros MA. The role of
anticoagulation in the development of pericardial effusion and late
tamponade after cardiac surgery. Eur Heart J 1993;11:1451–7.
4. Oakley CM. Myocarditis, pericarditis and other pericardial diseases.
Heart 2000;84:449–54.
5. Sagrista`-Sauleda J, Bonet LA, Ferrer JA, et al. The clinical practice
guidelines of the Sociedad Espanola de Cardiologia on pericardial
pathology. Rev Esp Cardiol 2000;53:394–412.
6. Lanza FL. A guideline for the treatment and prevention of NSAID-
induced ulcers. Members of the Ad Hoc Committee on Practice
Parameters of the American College of Gastroenterology. Am J
Gastroenterol 1998;93:2037–46.
7. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastro-
intestinal complications related to use of nonsteroidal anti-
inflammatory drugs: a meta-analysis. Ann Intern Med 1991;115:787–
96.
8. Shabetai R. Acute pericarditis. Cardiol Clin 1990;8:639–44.
9. Fowler NO. Recurrent pericarditis. Cardiol Clin 1990;8:621–6.
0. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for
recurrent pericarditis: a decade of experience. Circulation 1998;97:
2183–5.
